Inflammatory flare can show how quickly skin balance may shift when a specific trigger acts on a pre-existing rosacea tendency. In this case, medication appeared to precipitate visible redness, heightened sensitivity and barrier fragility, creating a pattern of reactivity that extended beyond the surface.
When vascular instability, inflammatory signalling, microbial imbalance and reduced cutaneous tolerance reinforce one another, the skin may become less able to self-regulate. Redness becomes more visible, sensitivity increases and the barrier may appear more fragile.
In this case supervised by Rita Baiguera, Director of SKINdiciotto, the objective was to identify the trigger, support the skin’s regulatory threshold and rebuild the conditions needed for improved tolerance, reduced reactivity and greater resilience over time.
Clinical focus
At baseline, the skin showed persistent redness, visible reactivity and barrier fragility, triggered by medication in a rosacea-prone context. The evolution observed over four weeks was consistent with reduced cutaneous sensitivity, greater stability and improved tolerance.
Photographs were taken at T0 baseline and T4, week 4. The protocol was conducted under the supervision of Rita Baiguera and combined daily oral intake of The Skin Biotic with twice-daily application of The Gentle Cleanser and The Active Cream.
The clinical priorities were:
→ Identify medication as a trigger of rosacea-like reactivity
→ Support regulation across the gut-skin axis
→ Improve microbial balance at the skin interface
→ Strengthen barrier function while easing visible inflammation
→ Soothe cutaneous reactivity and support immune homeostasis
How AWvi supported the skin
The Skin Biotic supported the systemic dimension of the protocol by contributing to gut microbiome balance, immune regulation and a healthier cutaneous environment. In a flare-prone context, this internal support aimed to help reduce inflammatory load and support the skin’s ability to regain stability from within.
The Gentle Cleanser supported the topical phase by cleansing without disrupting skin comfort. In reactive, redness-prone skin, the cleansing step is critical: removing impurities must not come at the cost of barrier comfort, surface microbiome balance or further sensitisation.
The Active Cream helped reinforce barrier function, comfort and daily stability. Its role was to support barrier lipids, calm visible reactivity and strengthen cutaneous defences through biomimetic ingredients aligned with skin physiology.
Together, the protocol reflected AWvi’s inside-out and outside-in approach: supporting the internal systems that influence inflammatory regulation while protecting the skin surface from additional disruption.
Expert insight
“This case illustrates how quickly a skin with an underlying rosacea tendency can lose its regulatory threshold when exposed to the wrong trigger.
The medication did not simply create redness; it appeared to unmask a deeper pattern of vascular over-response, barrier vulnerability and inflammatory instability.
In these cases, the visible flare is only the surface expression of a system that has become less able to self-regulate.
My role is to identify what has disrupted that threshold, then rebuild the conditions that allow the skin to recover control, reduce reactivity and respond with greater resilience over time.”
Rita Baiguera
Director of SKINdiciotto
Visible evolution
After four weeks, the skin appeared less reactive, calmer and more stable. The visible reduction in redness and sensitivity suggested improved tolerance and a stronger capacity for recovery.
This case illustrates that inflammatory flare should not be addressed only as visible redness. In a rosacea-prone context, the flare can indicate a collapse in the skin’s regulatory threshold, involving vascular over-response, barrier vulnerability, microbial imbalance and inflammatory instability.
By combining The Skin Biotic, The Gentle Cleanser and The Active Cream, the protocol helped support the skin from within and at the surface, creating more favourable conditions for reduced reactivity, improved tolerance and greater resilience over time.
Sources:
SKINdiciotto: lo spazio per la “calma della pelle” a Brescia
SKINDICIOTTO: la grande bellezza
Molecular Mechanisms in the Etiopathology of Rosacea: Systematic Review
Rosacea, Microbiome and Probiotics: The Gut-Skin Axis
Skin Barrier in Rosacea
Microbiota in Rosacea
Rosaceiform Dermatitis Associated with Topical Tacrolimus Treatment
